Profil
Rebecca Lin is currently a Director at Shanghai Rarestone Health Tech Group Co., Ltd. and a Senior Partner & Co Head at Eight Roads Capital Advisors (CHINA) since 2021.
Education includes an undergraduate degree from Shenzhen University conferred in 1994 and an MBA from The Wharton School of the University of Pennsylvania conferred in 2000.
Aktiva positioner av Rebecca Lin
| Företag | Position | Start |
|---|---|---|
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Privat kapitalinvesterare | 2007-06-01 |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services | Direktör/Styrelseledamot | - |
Rebecca Lins utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Shenzhen University
Shenzhen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eight Roads Capital Advisors (CHINA)
Eight Roads Capital Advisors (CHINA) Investment ManagersFinance Functions as an alternative investment manager | Finance |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services | Health Technology |
















